Anti-Oxidative Therapy in Diabetic Nephropathy
Frontiers in Bioscience-Scholar · 09.05.2022 · 14 (2)
DOI: 10.31083/j.fbs1402014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Scholar, online erschienen am 09.05.2022. Verfasst von Luis F Hernandez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Kidney and Pancreas Transplant, Department of Surgery, University of California, Irvine Medical Center, Orange, CA 92868, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Diabetic Nephropathies, Hyperglycemia. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chronic kidney disease is generally progressive and currently has no reliable treatment to reverse a decline in kidney function or to slow the progression of the disease. Diabetic nephropathy is one of the leading causes of end-stage kidney failure. Kidney damage in diabetic nephropathy is largely attributed to the increased oxidative stress, affecting its metabolic activity, metabolic pathways, and hemodynamic pathways. In diabetic patients, hyperglycemia causes an increase in the production of reactive oxygen species that further increase oxidative stress. These reactive oxygen species are created through a variety of pathways, providing the opportunity for treatment using anti-oxidative defense mechanisms to prevent vascular injury. This review will give an overview of oxidative stress, along with the current treatments and limitations of diabetic nephropathy. We will also discuss the potential of antioxidative therapies, with an emphasis on the nuclear factor erythroid 2–related factor 2 (Nrf2) pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Kidney and Pancreas Transplant, Department of Surgery, University of California, Irvine Medical Center, Orange, CA 92868, USA.
- Division of Nephrology and Hypertension, Department of Medicine, University of California, Irvine Medical Center, Orange, CA 92868, USA.
Zitieren
APA
Hernandez, L. F., Eguchi, N., Whaley, D., Alexander, M., Tantisattamo, E., & Ichii, H. (2022). Anti-Oxidative Therapy in Diabetic Nephropathy. Frontiers in Bioscience-Scholar, 14(2). https://doi.org/10.31083/j.fbs1402014
Vancouver
Hernandez LF, Eguchi N, Whaley D, Alexander M, Tantisattamo E, Ichii H. Anti-Oxidative Therapy in Diabetic Nephropathy. Frontiers in Bioscience-Scholar. 2022;14(2). doi:10.31083/j.fbs1402014
BibTeX
@article{Hernandez2022,
author = {Hernandez, Luis F and Eguchi, Natsuki and Whaley, David and Alexander, Michael and Tantisattamo, Ekamol and Ichii, Hirohito},
title = {Anti-Oxidative Therapy in Diabetic Nephropathy},
journal = {Frontiers in Bioscience-Scholar},
year = {2022},
volume = {14},
number = {2},
doi = {10.31083/j.fbs1402014}
}
EUVIMED